iifl-logo

Remus Pharmaceuticals Ltd Board Meeting

2,072.75
(-2.18%)
May 20, 2025|03:40:21 PM

Remus Pharma. CORPORATE ACTIONS

21/05/2024calendar-icon
21/05/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting17 May 202512 May 2025
To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matte To consider and approve the financial results for the period ended March 31, 2025, dividend, bonus and other business matters (As Per NSE Announcement Dated on:14.05.2025) Remus Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025. (As Per BSE Announcement Dated on: 16/05/2025)
Board Meeting27 Feb 202527 Feb 2025
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 27, 2025.
Board Meeting9 Nov 20245 Nov 2024
To consider and approve the financial results for the period ended September 30, 2024, interim dividend and other business matters REMUS PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 09-Nov-2024 for Dividend (As Per NSE Announcement Dated on: 09/11/2024)
Board Meeting14 Aug 202414 Aug 2024
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2024.
Board Meeting10 Jun 202410 Jun 2024
Remus Pharmaceuticals Limited has informed the Exchange regarding allotment of 4419000 equity shares pursuant to Bonus at its meeting held on Jun 10, 2024

Remus Pharma.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.